Elexacaftor/Tezacaftor/Ivacaftor Effect on Bone Density and Body Composition: A Retrospective Analysis. [PDF]
Pediatr PulmonolTrost SU +6 more
europepmc +1 more source
Beyond BMI: Nutritional Recovery and Functional Implications of CFTR Modulators in Cystic Fibrosis. [PDF]
Biology (Basel)Linguiti G +6 more
europepmc +1 more source
Cystic Fibrosis and CFTR Modulators: The Impact on Bone Density, Muscle Mass and Strength in Children and Young Adolescents. [PDF]
Children (Basel)Iordanidou K +6 more
europepmc +1 more source
Delayed-onset drug-induced liver injury in a cystic fibrosis patient on long-term elexacaftor/ivacaftor/tezacaftor therapy: A case report and literature review. [PDF]
Can Liver JAlenezi AF, Sachar Y, Sandhu A.
europepmc +1 more source
Evaluation of Elexacaftor/Tezacaftor/Ivacaftor-Mediated Drug-Induced Liver Injury Using a Liver-On-Chip Model. [PDF]
Clin Transl SciShi A, Agarwal P, Liu ZX, Beringer PM.
europepmc +1 more source
Real-World Outcomes of Elexacaftor/Tezacaftor/Ivacaftor in Children with Cystic Fibrosis. [PDF]
Ann Am Thorac SocPerrem L, McNally P.
europepmc +1 more source
L467F;F508del Complex Allele in a Heterozygous State with CFTRdele2,3: What to Expect from CFTR Modulators? [PDF]
Int J Mol SciKondratyeva E +10 more
europepmc +1 more source
Impact of Elexacaftor-Tezacaftor-Ivacaftor on Muscle Composition in Cystic Fibrosis: An AI-Assisted Chest CT-Based Body Composition Analysis. [PDF]
Med Sci (Basel)Welsner M +16 more
europepmc +1 more source